{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:56:40Z","timestamp":1795121800986,"version":"4.10.3"},"reference-count":218,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lab Anim Res"],"DOI":"10.1186\/s42826-026-00278-6","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:15:59Z","timestamp":1776071759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Intracerebroventricular streptozotocin-induced animal model of Alzheimer\u2019s disease: revealing dose optimization, administration regimen, and molecular pathways"],"prefix":"10.1186","volume":"42","author":[{"given":"Sagar A.","family":"More","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika N.","family":"Mundke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogeeta O.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay N.","family":"Awathale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer N.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik T.","family":"Nakhate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1402-548X","authenticated-orcid":false,"given":"Sumit S.","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"278_CR1","unstructured":"Kumar A, Sidhu J, Lui F, Tsao JW. Alzheimer disease. StatPearls. 2024 Feb.1\u201327."},{"key":"278_CR2","doi-asserted-by":"publisher","unstructured":"2023 Alzheimer\u2019s disease facts and figures. Alzheimers & Dementia. 2023 Apr;19(4):1598\u2013695. https:\/\/doi.org\/10.1002\/alz.13016.","DOI":"10.1002\/alz.13016"},{"key":"278_CR3","doi-asserted-by":"publisher","unstructured":"Tarawneh R, Holtzman DM. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med. 2012;2(5):a006148. https:\/\/doi.org\/10.1101\/cshperspect.a006148.","DOI":"10.1101\/cshperspect.a006148"},{"key":"278_CR4","doi-asserted-by":"publisher","unstructured":"Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegener. 2020 Jul;15(1). https:\/\/doi.org\/10.1186\/s13024-020-00391-7.","DOI":"10.1186\/s13024-020-00391-7"},{"issue":"5","key":"278_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jalz.2010.04.006","volume":"6","author":"K Iqbal","year":"2010","unstructured":"Iqbal K, Grundke-Iqbal I. Alzheimer\u2019s disease, a multifactorial disorder seeking multitherapies. Alzheimers & Dementia. 2010 Sep;6(5):420\u201324. https:\/\/doi.org\/10.1016\/j.jalz.2010.04.006.","journal-title":"Alzheimers &amp; Dementia"},{"issue":"4","key":"278_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30(4):572\u201380. https:\/\/doi.org\/10.1002\/ana.410300410.","journal-title":"Ann Neurol"},{"issue":"3","key":"278_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0165-5728(89)90115-X","volume":"24","author":"S Itagaki","year":"1989","unstructured":"Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol. 1989;24(3):173\u201382. https:\/\/doi.org\/10.1016\/0165-5728(89)90115-X.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"278_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3233\/JAD-2002-4313","volume":"4","author":"K Iqbal","year":"2002","unstructured":"Iqbal K, Grundke-Iqbal I. Neurofibrillary pathology leads to synaptic loss and not the other way around in Alzheimer disease. JAD. 2002;4(3):235\u201338. https:\/\/doi.org\/10.3233\/JAD-2002-4313.","journal-title":"JAD"},{"key":"278_CR9","doi-asserted-by":"publisher","unstructured":"Katsumoto A, Takeuchi H, Takahashi K, Tanaka F. Microglia in Alzheimer\u2019s disease: risk factors and inflammation. Front Neurol. 2018 Nov; 9(NOV).9. https:\/\/doi.org\/10.3389\/fneur.2018.00978.","DOI":"10.3389\/fneur.2018.00978"},{"issue":"5","key":"278_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00702-017-1831-7","volume":"125","author":"C Dansokho","year":"2018","unstructured":"Dansokho C, Heneka MT. Neuroinflammatory responses in Alzheimer\u2019s disease. J Neural Transm. 2018 May;125(5):771\u201379. https:\/\/doi.org\/10.1007\/s00702-017-1831-7.","journal-title":"J Neural Transm"},{"issue":"4","key":"278_CR11","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","volume":"57","author":"E T\u00f6nnies","year":"2017","unstructured":"T\u00f6nnies E, Trushina E. Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2017;57(4):1105\u201321. https:\/\/doi.org\/10.3233\/JAD-161088.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"278_CR12","doi-asserted-by":"crossref","unstructured":"Hoyer S, Muller D, Plaschke K. Desensitization of brain insulin receptor. Effect on glucose\/energy and related metabolism. J Educ Chang Neural Transm, Supplement. 1994.","DOI":"10.1007\/978-3-7091-9350-1_20"},{"issue":"1","key":"278_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00702-012-0877-9","volume":"120","author":"M Salkovic-Petrisic","year":"2013","unstructured":"Salkovic-Petrisic M, Knezovic A, Hoyer S, Riederer P. What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer\u2019s disease, about the therapeutic strategies in Alzheimer\u2019s research. J Neural Transm. 2013;120(1):233\u201352. https:\/\/doi.org\/10.1007\/s00702-012-0877-9.","journal-title":"J Neural Transm"},{"key":"278_CR14","doi-asserted-by":"publisher","unstructured":"Zhu Y, Verkhratsky A, Chen H, Yi C. Understanding glucose metabolism and insulin action at the blood\u2013brain barrier: implications for brain health and neurodegenerative diseases. Acta Physiologica. 2025;241(2):e14283. https:\/\/doi.org\/10.1111\/apha.14283.","DOI":"10.1111\/apha.14283"},{"issue":"1","key":"278_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1749-6632.2000.tb06932.x","volume":"920","author":"S Hoyer","year":"2000","unstructured":"Hoyer S, Kyung Lee SAE, L\u00f6ffler T, Schliebs R. Inhibition of the neuronal insulin receptor an in vivo model for sporadic Alzheimer disease? Ann New Y Acad Sci. 2000;920(1):256\u201358. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06932.x.","journal-title":"Ann New Y Acad Sci"},{"issue":"7","key":"278_CR16","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1097\/00001756-199307000-00039","volume":"4","author":"S Hoyer","year":"1993","unstructured":"Hoyer S, Prem L, Sorbi S, Amaducci L. Stimulation of glycolytic key enzymes in cerebral cortex by insulin. Neuroreport. 1993;4(7):991. https:\/\/doi.org\/10.1097\/00001756-199307000-00039.","journal-title":"Neuroreport"},{"issue":"1","key":"278_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM. Alzheimer\u2019s disease. Euro J Neurol. 2018;25(1):59\u201370. https:\/\/doi.org\/10.1111\/ene.13439.","journal-title":"Euro J Neurol"},{"issue":"2","key":"278_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s12035-012-8375-5","volume":"47","author":"Y Chen","year":"2013","unstructured":"Chen Y, Liang Z, Blanchard J, Dai CL, Sun S, Lee MH, et al. A non-transgenic mouse model (icv-STZ mouse) of Alzheimer\u2019s disease: similarities to and differences from the transgenic model (3xTg-AD mouse). Mol Neurobiol. 2013;47(2):711\u201325. https:\/\/doi.org\/10.1007\/s12035-012-8375-5.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"278_CR19","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.expneurol.2003.08.015","volume":"184","author":"S Shoham","year":"2003","unstructured":"Shoham S, Bejar C, Kovalev E, Weinstock M. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol. 2003 Dec;184(2):1043\u201352. https:\/\/doi.org\/10.1016\/j.expneurol.2003.08.015.","journal-title":"Exp Neurol"},{"issue":"0","key":"278_CR20","doi-asserted-by":"publisher","first-page":"594","DOI":"10.5455\/OVJ.2025.v15.i2.8","volume":"15","author":"N Titisari","year":"2025","unstructured":"Titisari N, Ahmad H, Samsulrizal N, Fauzi A, Razak ISA. The mechanism underlying streptozotocin injection for the development of a nontransgenic Alzheimer\u2019s disease animal model. Open Vet J. 2025;15(0):594. https:\/\/doi.org\/10.5455\/OVJ.2025.v15.i2.8.","journal-title":"Open Vet J"},{"issue":"1","key":"278_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-2006-9102","volume":"9","author":"N Lester-Coll","year":"2006","unstructured":"Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, De La Monte SM. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer\u2019s disease. JAD. 2006 Apr;9(1):13\u201333. https:\/\/doi.org\/10.3233\/JAD-2006-9102.","journal-title":"JAD"},{"issue":"4","key":"278_CR22","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s10787-025-01695-0","volume":"33","author":"MES Sorial","year":"2025","unstructured":"Sorial MES, Abdelghany RM, El Sayed NSED. Modulation of the cognitive impairment associated with Alzheimer\u2019s disease by valproic acid: possible drug repurposing. Inflammopharmacology. 2025;33(4):2083\u201394. https:\/\/doi.org\/10.1007\/s10787-025-01695-0.","journal-title":"Inflammopharmacology"},{"issue":"8","key":"278_CR23","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1021\/acs.jcim.5c00106","volume":"65","author":"S Swain","year":"2025","unstructured":"Swain S, Metya AK. Exploring Metformin\u2019s therapeutic potential for Alzheimer\u2019s disease: an in-Silico perspective using well-tempered funnel metadynamics. J Chem Inf Model. 2025;65(8):4163\u201372. https:\/\/doi.org\/10.1021\/acs.jcim.5c00106.","journal-title":"J Chem Inf Model"},{"issue":"1","key":"278_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/156720512799015037","volume":"9","author":"M. de la Monte","year":"2012","unstructured":"M. de la Monte, M. de la Monte S. Brain insulin resistance and deficiency as therapeutic targets in Alzheimers disease. CAR. 2012 Jan;9(1):35\u201366. https:\/\/doi.org\/10.2174\/156720512799015037.","journal-title":"CAR"},{"issue":"7","key":"278_CR25","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1007\/s12035-015-9384-y","volume":"53","author":"PK Kamat","year":"2016","unstructured":"Kamat PK, Kalani A, Rai S, Tota SK, Kumar A, Ahmad AS. Streptozotocin intracerebroventricular-induced neurotoxicity and brain insulin resistance: a therapeutic Intervention for treatment of sporadic Alzheimer\u2019s disease (sAD)-like pathology. Mol Neurobiol. 2016 Sep;53(7):4548\u201362. https:\/\/doi.org\/10.1007\/s12035-015-9384-y.","journal-title":"Mol Neurobiol"},{"key":"278_CR26","doi-asserted-by":"publisher","first-page":"1104985","DOI":"10.3389\/fnins.2023.1104985","volume":"17","author":"E Gr\u00fcnblatt","year":"2023","unstructured":"Gr\u00fcnblatt E, Homolak J, Babic Perhoc A, Davor V, Knezovic A, Osmanovic Barilar J, et al. From attention-deficit hyperactivity disorder to sporadic Alzheimer\u2019s disease\u2014Wnt\/mTOR pathways hypothesis. Front Neurosci. 2023;17:1104985. https:\/\/doi.org\/10.3389\/fnins.2023.1104985.","journal-title":"Front. Neurosci"},{"issue":"5","key":"278_CR27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10072-013-1594-3","volume":"35","author":"W Yang","year":"2014","unstructured":"Yang W, Ma J, Liu Z, Lu Y, Hu B, Yu H. Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats. Neurol. Sci. 2014;35(5):741\u201351. https:\/\/doi.org\/10.1007\/s10072-013-1594-3.","journal-title":"Neurol. Sci"},{"issue":"3","key":"278_CR28","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s12035-015-9132-3","volume":"53","author":"P Grieb","year":"2016","unstructured":"Grieb P. Intracerebroventricular streptozotocin injections as a model of Alzheimer\u2019s disease: in search of a relevant mechanism - [scite report]. Mol Neurobiol. 2016;53(3):1741\u201352. https:\/\/doi.org\/10.1007\/s12035-015-9132-3.","journal-title":"Mol Neurobiol"},{"key":"278_CR29","unstructured":"Pfutzenreuter G. Streptozotocin-induced neurodegeneration in wistar rats: short and long term effects on behavior and brain gene expression. 2017."},{"key":"278_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","volume":"52","author":"SH Barage","year":"2015","unstructured":"Barage SH, Sonawane KD. Amyloid cascade hypothesis: pathogenesis and therapeutic strategies in Alzheimer\u2019s disease. Neuropeptides. 2015;52:1\u201318. https:\/\/doi.org\/10.1016\/j.npep.2015.06.008.","journal-title":"Neuropeptides"},{"key":"278_CR31","doi-asserted-by":"publisher","unstructured":"Ijezie EC, Miller MJ, Hardy C, Jarvis AR, Czajka TF, D\u2019Brant L, et al. Herpes simplex virus-1 infection alters microtubule-associated protein tau splicing and promotes tau pathology in neural models of Alzheimer\u2019s disease. Brain Pathol. 2025;35(5):e70006. https:\/\/doi.org\/10.1111\/bpa.70006.","DOI":"10.1111\/bpa.70006"},{"issue":"2","key":"278_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/cells14020089","volume":"14","author":"EH Ahn","year":"2025","unstructured":"Ahn EH, Park JB. Molecular mechanisms of Alzheimer\u2019s disease induced by amyloid-\u03b2 and tau phosphorylation along with RhoA activity: perspective of RhoA\/Rho-associated protein kinase inhibitors for neuronal therapy. Cells. 2025;14(2):89. https:\/\/doi.org\/10.3390\/cells14020089.","journal-title":"Cells"},{"key":"278_CR33","doi-asserted-by":"publisher","first-page":"1540019","DOI":"10.3389\/fnagi.2025.1540019","volume":"17","author":"FX Liu","year":"2025","unstructured":"Liu FX, Yang SZ, Shi KK, Li DM, Song J-B, Sun L, et al. The role of protein phosphorylation modifications mediated by iron metabolism regulatory networks in the pathogenesis of Alzheimer\u2019s disease. Front Aging Neurosci. 2025;17:1540019. https:\/\/doi.org\/10.3389\/fnagi.2025.1540019.","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"278_CR34","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1055\/a-2238-1384","volume":"56","author":"A Singh","year":"2024","unstructured":"Singh A, Ansari VA, Mahmood T, Hasan SM, Wasim R, Maheshwari S, et al. Targeting abnormal tau phosphorylation for Alzheimer\u2019s therapeutics. Horm Metab Res. 2024;56(7):482\u201388. https:\/\/doi.org\/10.1055\/a-2238-1384.","journal-title":"Horm Metab Res"},{"issue":"4","key":"278_CR35","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/ana.410200407","volume":"20","author":"CG Rasool","year":"1986","unstructured":"Rasool CG, Svendsen CN, Selkoe DJ. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer\u2019s disease. Ann Neurol. 1986 Oct;20(4):482\u201388. https:\/\/doi.org\/10.1002\/ana.410200407.","journal-title":"Ann Neurol"},{"key":"278_CR36","doi-asserted-by":"publisher","first-page":"1376764","DOI":"10.3389\/fnagi.2024.1376764","volume":"16","author":"L Jiao","year":"2024","unstructured":"Jiao L, Kang H, Geng Y, Liu X, Wang M, Shu K. The role of the nucleus basalis of Meynert in neuromodulation therapy: a systematic review from the perspective of neural network oscillations. Front Aging Neurosci. 2024;16:1376764. https:\/\/doi.org\/10.3389\/fnagi.2024.1376764.","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"278_CR37","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain. 2018;141(7):1917\u201333. https:\/\/doi.org\/10.1093\/brain\/awy132.","journal-title":"Brain"},{"key":"278_CR38","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.2147\/JIR.S483412","volume":"Volume 17","author":"S Zhang","year":"2024","unstructured":"Zhang S, Gao Z, Feng L, Li M. Prevention and treatment strategies for Alzheimer\u2019s disease: focusing on microglia and astrocytes in neuroinflammation. JIR. 2024;Volume 17:7235\u201359. https:\/\/doi.org\/10.2147\/JIR.S483412.","journal-title":"JIR"},{"key":"278_CR39","doi-asserted-by":"crossref","unstructured":"Singh N, Kumar K, Kaur S, Kandpal A, Yadav HN, Singh D, et al. Pathophysiology and diagnosis of Alzheimer\u2019s disease: past and recent developments. Neuro-Nutraceuticals Drug Discov Deliv Alzheimer\u2019s Dis. 2025;3\u201335.","DOI":"10.1201\/9781003570356-2"},{"issue":"34","key":"278_CR40","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1073\/pnas.0903563106","volume":"106","author":"J Yao","year":"2009","unstructured":"Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2009;106(34):14670\u201375. https:\/\/doi.org\/10.1073\/pnas.0903563106.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"278_CR41","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","volume":"21","author":"K Hirai","year":"2001","unstructured":"Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, et al. Mitochondrial Abnormalities in Alzheimer\u2019s Disease. J Neurosci. 2001;21(9):3017\u201323. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-09-03017.2001.","journal-title":"J Neurosci"},{"issue":"5923","key":"278_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1126\/science.1171091","volume":"324","author":"DH Cho","year":"2009","unstructured":"Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, et al. S-nitrosylation of Drp1 mediates \u03b2-amyloid-related mitochondrial fission and neuronal injury. Sci (80-). 2009;324(5923):102\u201305. https:\/\/doi.org\/10.1126\/science.1171091.","journal-title":"Sci (80-)"},{"issue":"11","key":"278_CR43","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41582-022-00714-w","volume":"18","author":"L Migliore","year":"2022","unstructured":"Migliore L, Copped\u00e8 F. Gene\u2013environment interactions in Alzheimer disease: the emerging role of epigenetics. Nat Rev Neurol. 2022;18(11):643\u201360. https:\/\/doi.org\/10.1038\/s41582-022-00714-w.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"278_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.trci.2017.04.001","volume":"3","author":"MJ Wheeler","year":"2017","unstructured":"Wheeler MJ, Dempsey PC, Grace MS, Ellis KA, Gardiner PA, Green DJ, et al. Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health. A D Transl Res Clin Interv. 2017;3(3):291\u2013300. https:\/\/doi.org\/10.1016\/j.trci.2017.04.001.","journal-title":"A D Transl Res Clin Interv"},{"issue":"4","key":"278_CR45","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/ijms21041505","volume":"21","author":"YC Kao","year":"2020","unstructured":"Kao YC, Ho PC, Tu YK, Jou IM, Tsai KJ. Lipids and Alzheimer\u2019s disease. IJMS. 2020;21(4):1505. https:\/\/doi.org\/10.3390\/ijms21041505.","journal-title":"IJMS"},{"issue":"3","key":"278_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s43587-021-00043-5","volume":"1","author":"WA Banks","year":"2021","unstructured":"Banks WA, Reed MJ, Logsdon AF, Rhea EM, Erickson MA. Healthy aging and the blood\u2013brain barrier. Nat Aging. 2021;1(3):243\u201354. https:\/\/doi.org\/10.1038\/s43587-021-00043-5.","journal-title":"Nat Aging"},{"issue":"6","key":"278_CR47","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.mehy.2015.09.005","volume":"85","author":"JY Hahr","year":"2015","unstructured":"Hahr JY. Physiology of the Alzheimer\u2019s disease. Med Hypotheses. 2015;85(6):944\u201346. https:\/\/doi.org\/10.1016\/j.mehy.2015.09.005.","journal-title":"Med Hypotheses"},{"issue":"1","key":"278_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"H-F Yan","year":"2021","unstructured":"Yan H-F, Zou T, Tuo QZ, Xu S, Li H, Belaidi AA, et al. Ferroptosis: mechanisms and links with diseases. Sig Transduct Target Ther. 2021;6(1):49. https:\/\/doi.org\/10.1038\/s41392-020-00428-9.","journal-title":"Sig Transduct Target Ther"},{"key":"278_CR49","doi-asserted-by":"publisher","unstructured":"Lanoisel\u00e9e HM, Nicolas G, Wallon D, Rovelet-Lecrux A, Lacour M, Rousseau S, et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med. 2017 Mar;14(3):e1002270. https:\/\/doi.org\/10.1371\/journal.pmed.1002270.","DOI":"10.1371\/journal.pmed.1002270"},{"issue":"1","key":"278_CR50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ajmg.b.30087","volume":"132B","author":"EM Wijsman","year":"2005","unstructured":"Wijsman EM, Daw EW, Yu X, Steinbart EJ, Nochlin D, Bird TD, et al. APOE and other loci affect age-at-onset in Alzheimer\u2019s disease families with PS2 mutation. Am J Med Genet Pt B. 2005;132B(1):14\u201320. https:\/\/doi.org\/10.1002\/ajmg.b.30087.","journal-title":"Am J Med Genet Pt B"},{"issue":"2","key":"278_CR51","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JAD-170061","volume":"58","author":"XZ Yuan","year":"2017","unstructured":"Yuan XZ, Sun S, Tan CC, Yu JT, Tan L. The role of ADAM10 in Alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2017;58(2):303\u201322. https:\/\/doi.org\/10.3233\/JAD-170061.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"2","key":"278_CR52","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neuron.2013.09.031","volume":"80","author":"R Vassar","year":"2013","unstructured":"Vassar R. ADAM10 prodomain mutations cause late-onset Alzheimer\u2019s disease: not just the latest FAD. Neuron. 2013 Oct;80(2):250\u201353. https:\/\/doi.org\/10.1016\/j.neuron.2013.09.031.","journal-title":"Neuron"},{"issue":"2","key":"278_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40828-021-00140-3","volume":"7","author":"S Lenzen","year":"2021","unstructured":"Lenzen S. The pancreatic beta cell: an intricate relation between anatomical structure, the signalling mechanism of glucose-induced insulin secretion, the low antioxidative defence, the high vulnerability and sensitivity to diabetic stress. ChemTexts. 2021;7(2):13. https:\/\/doi.org\/10.1007\/s40828-021-00140-3.","journal-title":"ChemTexts"},{"key":"278_CR54","doi-asserted-by":"publisher","first-page":"1395887","DOI":"10.3389\/fphar.2024.1395887","volume":"15","author":"Y Lin","year":"2024","unstructured":"Lin Y, Du W, Fu X, Huang L, Hong Y, Tan H, et al. Hyperglycemia-independent neonatal streptozotocin-induced retinopathy (NSIR) in rats. Front Pharmacol. 2024;15:1395887. https:\/\/doi.org\/10.3389\/fphar.2024.1395887.","journal-title":"Front Pharmacol"},{"issue":"8","key":"278_CR55","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/0736-5748(94)90053-1","volume":"12","author":"R Duelli","year":"1994","unstructured":"Duelli R, Schr\u00f6ck H, Kuschinsky W, Hoyer S. Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Intl J Devlp Neurosci. 1994;12(8):737\u201343. https:\/\/doi.org\/10.1016\/0736-5748(94)90053-1.","journal-title":"Intl J Devlp Neurosci"},{"issue":"2","key":"278_CR56","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0304-3940(91)90260-Z","volume":"128","author":"R Nitsch","year":"1991","unstructured":"Nitsch R, Hoyer S. Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci Lett. 1991;128(2):199\u2013202. https:\/\/doi.org\/10.1016\/0304-3940(91)90260-Z.","journal-title":"Neurosci Lett"},{"key":"278_CR57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbr.2017.11.015","volume":"339","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Huang N-Q, Yan F, Jin H, Zhou S-Y, Shi J-S, et al. Diabetes mellitus and Alzheimer\u2019s disease: GSK-3\u03b2 as a potential link. Behav Brain Res. 2018;339:57\u201365. https:\/\/doi.org\/10.1016\/j.bbr.2017.11.015.","journal-title":"Behavioural Brain Res"},{"issue":"4","key":"278_CR58","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13205-021-02738-3","volume":"11","author":"M Zheng","year":"2021","unstructured":"Zheng M, Wang P. Role of insulin receptor substance-1 modulating PI3K\/Akt insulin signaling pathway in Alzheimer\u2019s disease. 3 Biotech. 2021;11(4):179. https:\/\/doi.org\/10.1007\/s13205-021-02738-3.","journal-title":"3 Biotech"},{"issue":"5","key":"278_CR59","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00702-011-0651-4","volume":"118","author":"M Salkovic-Petrisic","year":"2011","unstructured":"Salkovic-Petrisic M, Osmanovic-Barilar J, Br\u00fcckner MK, Hoyer S, Arendt T, Riederer P. Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer\u2019s disease: a long-term follow up study. J Neural Transm. 2011;118(5):765\u201372. https:\/\/doi.org\/10.1007\/s00702-011-0651-4.","journal-title":"J Neural Transm"},{"issue":"7","key":"278_CR60","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.3390\/ijms23073785","volume":"23","author":"CG Ardanaz","year":"2022","unstructured":"Ardanaz CG, Ram\u00edrez MJ, Solas M. Brain metabolic alterations in Alzheimer\u2019s disease. IJMS. 2022;23(7):3785. https:\/\/doi.org\/10.3390\/ijms23073785.","journal-title":"IJMS"},{"issue":"10","key":"278_CR61","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00702-025-02891-6","volume":"132","author":"E Gr\u00fcnblatt","year":"2025","unstructured":"Gr\u00fcnblatt E, Yde Ohki CM, Schmitt-B\u00f6hrer GA, Riederer P, Walitza S. Exploring the interplay of glucose metabolism, insulin resistance, and neurodegenerative pathologies: insights from streptozotocin and hypoglycaemic in vitro models. J Neural Transm. 2025;132(10):1479\u201391. https:\/\/doi.org\/10.1007\/s00702-025-02891-6.","journal-title":"J Neural Transm"},{"key":"278_CR62","doi-asserted-by":"publisher","unstructured":"Poddar J, Singh S, Kumar P, Bali S, Gupta S, Chakrabarti S. Inhibition of complex I-III activity of brain mitochondria after intracerebroventricular administration of streptozotocin in rats is possibly related to loss of body weight. Heliyon. 2020;6(7):e04490. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04490.","DOI":"10.1016\/j.heliyon.2020.e04490"},{"key":"278_CR63","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neuroscience.2017.04.011","volume":"353","author":"IM Esteves","year":"2017","unstructured":"Esteves IM, Lopes-Aguiar C, Rossignoli MT, Ruggiero RN, Broggini ACS, Bueno-Junior LS, et al. Chronic nicotine attenuates behavioral and synaptic plasticity impairments in a streptozotocin model of Alzheimer\u2019s disease. Neuroscience. 2017;353:87\u201397. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.04.011.","journal-title":"Neuroscience"},{"issue":"12","key":"278_CR64","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00702-018-1928-7","volume":"125","author":"MF Zappa Villar","year":"2018","unstructured":"Zappa Villar MF, L\u00f3pez Hanotte J, Falomir Lockhart E, Tr\u00edpodi LS, Morel GR, Reggiani PC, et al. Intracerebroventricular streptozotocin induces impaired Barnes maze spatial memory and reduces astrocyte branching in the CA1 and CA3 hippocampal regions. J Neural Transm. 2018;125(12):1787\u2013803. https:\/\/doi.org\/10.1007\/s00702-018-1928-7.","journal-title":"J Neural Transm"},{"issue":"12","key":"278_CR65","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/brainsci10120923","volume":"10","author":"V Verma","year":"2020","unstructured":"Verma V, Singh D, Reeta KH. Sinapic acid alleviates oxidative stress and neuro-inflammatory changes in sporadic model of alzheimer\u2019s disease in rats. Brain Sci. 2020;10(12):923. https:\/\/doi.org\/10.3390\/brainsci10120923.","journal-title":"Brain Sci"},{"issue":"3","key":"278_CR66","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.physbeh.2012.06.019","volume":"107","author":"TDO Santos","year":"2012","unstructured":"Santos T de O, Mazucanti CHY, Xavier GF, da Silva Torr\u00e3o A. Early and late neurodegeneration and memory disruption after intracerebroventricular streptozotocin. Physiol Behav. 2012;107(3):401\u201313. https:\/\/doi.org\/10.1016\/j.physbeh.2012.06.019.","journal-title":"Physiol Behav"},{"issue":"8","key":"278_CR67","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0006-2952(98)00370-0","volume":"57","author":"M Murata","year":"1999","unstructured":"Murata M, Takahashi A, Saito I, Kawanishi S. Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozotocin. Biochemical Pharmacol [Internet]. 1999;57(8):881\u201387. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0006295298003700.","journal-title":"Biochemical Pharmacol"},{"key":"278_CR68","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuropharm.2014.08.013","volume":"86","author":"N Rajasekar","year":"2014","unstructured":"Rajasekar N, Dwivedi S, Nath C, Hanif K, Shukla R. Protection of streptozotocin induced insulin receptor dysfunction, neuroinflammation and amyloidogenesis in astrocytes by insulin. Neuropharmacology. 2014;86:337\u201352. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.08.013.","journal-title":"Neuropharmacology"},{"key":"278_CR69","doi-asserted-by":"publisher","first-page":"205873841986637","DOI":"10.1177\/2058738419866379","volume":"33","author":"M Liu","year":"2019","unstructured":"Liu M, Gao L, Zhang N. Berberine reduces neuroglia activation and inflammation in streptozotocin-induced diabetic mice. Int J Immunopathol Pharmacol. 2019;33:2058738419866379. https:\/\/doi.org\/10.1177\/2058738419866379.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"278_CR70","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.pbb.2011.08.019","volume":"100","author":"PK Kamat","year":"2011","unstructured":"Kamat PK, Tota S, Shukla R, Ali S, Najmi AK, Nath C. Mitochondrial dysfunction: a crucial event in okadaic acid (ICV) induced memory impairment and apoptotic cell death in rat brain. Pharmacol Biochem Behav. 2011;100(2):311\u201319. https:\/\/doi.org\/10.1016\/j.pbb.2011.08.019.","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"278_CR71","doi-asserted-by":"publisher","first-page":"638467","DOI":"10.1155\/2008\/638467","volume":"2008","author":"I Jafari Anarkooli","year":"2008","unstructured":"Jafari Anarkooli I, Sankian M, Ahmadpour S, Varasteh AR, Haghir H. Evaluation of Bcl-2 family gene expression and Caspase-3 activity in hippocampus STZ-Induced diabetic rats. J Diabetes Res. 2008;2008(1):638467. https:\/\/doi.org\/10.1155\/2008\/638467.","journal-title":"J Diabetes Res"},{"issue":"6","key":"278_CR72","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s001250051217","volume":"42","author":"M Di Luca","year":"1999","unstructured":"Di Luca M, Ruts L, Gardoni F, Cattabeni F, Biessels GJ, Gispen WH. NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats. Diabetologia. 1999;42(6):693\u2013701. https:\/\/doi.org\/10.1007\/s001250051217.","journal-title":"Diabetologia"},{"key":"278_CR73","doi-asserted-by":"publisher","first-page":"154594","DOI":"10.1016\/j.phymed.2022.154594","volume":"109","author":"P Liu","year":"2023","unstructured":"Liu P, Wang C, Chen W, Kang Y, Liu W, Qiu Z, et al. Inhibition of GluN2B pathway is involved in the neuroprotective effect of silibinin on streptozotocin-induced Alzheimer\u2019s disease models. Phytomedicine. 2023;109:154594. https:\/\/doi.org\/10.1016\/j.phymed.2022.154594.","journal-title":"Phytomedicine"},{"issue":"1","key":"278_CR74","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000097511","volume":"79","author":"A Kumar","year":"2007","unstructured":"Kumar A, Naidu PS, Seghal N, Padi SSV. Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology. 2007;79(1):17\u201326. https:\/\/doi.org\/10.1159\/000097511.","journal-title":"Pharmacology"},{"issue":"1","key":"278_CR75","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbr.2011.04.039","volume":"224","author":"G Saxena","year":"2011","unstructured":"Saxena G, Patro IK, Nath C. ICV STZ induced impairment in memory and neuronal mitochondrial function: a protective role of nicotinic receptor. Behavioural Brain Res. 2011;224(1):50\u201357. https:\/\/doi.org\/10.1016\/j.bbr.2011.04.039.","journal-title":"Behavioural Brain Res"},{"issue":"4","key":"278_CR76","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.neuropharm.2009.01.005","volume":"56","author":"R Agrawal","year":"2009","unstructured":"Agrawal R, Tyagi E, Shukla R, Nath C. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia. Neuropharmacology. 2009;56(4):779\u201387. https:\/\/doi.org\/10.1016\/j.neuropharm.2009.01.005.","journal-title":"Neuropharmacology"},{"issue":"3","key":"278_CR77","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ejphar.2007.12.009","volume":"581","author":"G Saxena","year":"2008","unstructured":"Saxena G, Singh SP, Agrawal R, Nath C. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Eur J Pharmacol. 2008;581(3):283\u201389. https:\/\/doi.org\/10.1016\/j.ejphar.2007.12.009.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"278_CR78","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.neuropharm.2006.10.005","volume":"52","author":"S Shoham","year":"2007","unstructured":"Shoham S, Bejar C, Kovalev E, Schorer-Apelbaum D, Weinstock M. Ladostigil prevents gliosis, oxidative\u2013nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology. 2007;52(3):836\u201343. https:\/\/doi.org\/10.1016\/j.neuropharm.2006.10.005.","journal-title":"Neuropharmacology"},{"key":"278_CR79","doi-asserted-by":"publisher","first-page":"1161678","DOI":"10.3389\/fnagi.2023.1161678","volume":"15","author":"JB Stanojevic","year":"2023","unstructured":"Stanojevic JB, Zeljkovic M, Dragic M, Stojanovic IR, Ilic T V, Stevanovic ID, et al. Intermittent theta burst stimulation attenuates oxidative stress and reactive astrogliosis in the streptozotocin-induced model of Alzheimer\u2019s disease-like pathology. Front Aging Neurosci. 2023 May;15:1161678. https:\/\/doi.org\/10.3389\/fnagi.2023.1161678.","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"278_CR80","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.euroneuro.2009.02.002","volume":"19","author":"T Ishrat","year":"2009","unstructured":"Ishrat T, Hoda MN, Khan MB, Yousuf S, Ahmad M, Khan MM, et al. Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer\u2019s type (SDAT). Eur Neuropsychopharmacol. 2009;19(9):636\u201347. https:\/\/doi.org\/10.1016\/j.euroneuro.2009.02.002.","journal-title":"Eur Neuropsychopharmacol"},{"key":"278_CR81","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.brainres.2009.04.010","volume":"1281","author":"T Ishrat","year":"2009","unstructured":"Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, Yousuf S, et al. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer\u2019s type. Brain Res. 2009;1281:117\u201327. https:\/\/doi.org\/10.1016\/j.brainres.2009.04.010.","journal-title":"Brain Res"},{"issue":"3\u20134","key":"278_CR82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.lfs.2009.11.007","volume":"86","author":"H Awasthi","year":"2010","unstructured":"Awasthi H, Tota S, Hanif K, Nath C, Shukla R. Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow. Life Sci. 2010;86(3\u20134):87\u201394. https:\/\/doi.org\/10.1016\/j.lfs.2009.11.007.","journal-title":"Life Sci"},{"issue":"2","key":"278_CR83","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbr.2008.11.044","volume":"199","author":"S Tota","year":"2009","unstructured":"Tota S, Kamat PK, Awasthi H, Singh N, Raghubir R, Nath C, et al. Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin. Behavioural Brain Res. 2009;199(2):235\u201340. https:\/\/doi.org\/10.1016\/j.bbr.2008.11.044.","journal-title":"Behavioural Brain Res"},{"key":"278_CR84","doi-asserted-by":"crossref","unstructured":"Gulyaeva N V, Bobkova N V, Kolosova NG, Samokhin AN, Stepanichev MY, Stefanova NA. Molecular and cellular mechanisms of sporadic Alzheimer\u2019s disease: studies on rodent models in vivo. Vol. 82. Biochemistry (Moscow); 2017.","DOI":"10.1134\/S0006297917100029"},{"key":"278_CR85","volume-title":"Neuroinflammation in Alzheimer\u2019s disease: protector or promoter?","author":"N Zilka","year":"2006","unstructured":"Zilka N, Ferencik M, Hulin I. Neuroinflammation in Alzheimer\u2019s disease: protector or promoter? Vol. 107. Bratislavsk\u00e9 lek\u00e1rske listy; 2006."},{"issue":"19\u201320","key":"278_CR86","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.lfs.2012.03.012","volume":"90","author":"PK Kamat","year":"2012","unstructured":"Kamat PK, Tota S, Rai S, Swarnkar S, Shukla R, Nath C. A study on neuroinflammatory marker in brain areas of okadaic acid (ICV) induced memory impaired rats. Life Sci. 2012;90(19\u201320):713\u201320. https:\/\/doi.org\/10.1016\/j.lfs.2012.03.012.","journal-title":"Life Sci"},{"issue":"6","key":"278_CR87","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0197-4580(01)00287-1","volume":"22","author":"RE Mrak","year":"2001","unstructured":"Mrak RE. Interleukin-1, neuroinflammation, and Alzheimer\u2019s disease. Neurobiol Aging. 2001;22(6):903\u201308. https:\/\/doi.org\/10.1016\/S0197-4580(01)00287-1.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"278_CR88","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-9-197","volume":"9","author":"M Ifuku","year":"2012","unstructured":"Ifuku M, Katafuchi T, Mawatari S, Noda M, Miake K, Sugiyama M, et al. Anti-inflammatory\/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult mice. J Neuroinflammation. 2012;9(1):9. https:\/\/doi.org\/10.1186\/1742-2094-9-197.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"278_CR89","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1196\/annals.1403.002","volume":"1122","author":"SD Skaper","year":"2007","unstructured":"Skaper SD. The brain as a target for inflammatory processes and neuroprotective strategies. Ann New Y Acad Sci. 2007;1122(1):23\u201334. https:\/\/doi.org\/10.1196\/annals.1403.002.","journal-title":"Ann New Y Acad Sci"},{"issue":"1","key":"278_CR90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/JAD-2011-110821","volume":"28","author":"S Ricci","year":"2012","unstructured":"Ricci S, Fuso A, Ippoliti F, Businaro R. Stress-induced cytokines and neuronal dysfunction in Alzheimer\u2019s disease. JAD. 2012;28(1):11\u201324. https:\/\/doi.org\/10.3233\/JAD-2011-110821.","journal-title":"JAD"},{"issue":"3","key":"278_CR91","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.bbi.2007.08.014","volume":"22","author":"J Chen","year":"2008","unstructured":"Chen J, Buchanan JB, Sparkman NL, Godbout JP, Freund GG, Johnson RW. Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun. 2008;22(3):301\u201311. https:\/\/doi.org\/10.1016\/j.bbi.2007.08.014.","journal-title":"Brain Behav Immun"},{"key":"278_CR92","volume-title":"Neuroinflammation and cognitive aging","author":"RL Ownby","year":"2010","unstructured":"Ownby RL. Neuroinflammation and cognitive aging. Vol. 12. Current Psychiatry Reports; 2010."},{"issue":"2","key":"278_CR93","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbi.2003.11.003","volume":"18","author":"WA Banks","year":"2004","unstructured":"Banks WA. Neuroimmune networks and communication pathways: the importance of location. Brain Behav Immun. 2004;18(2):120\u201322. https:\/\/doi.org\/10.1016\/j.bbi.2003.11.003.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"278_CR94","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0165-3806(01)00110-9","volume":"127","author":"R Schechter","year":"2001","unstructured":"Schechter R, Abboud M. Neuronal synthesized insulin roles on neural differentiation within fetal rat neuron cell cultures. Dev Brain Res. 2001;127(1):41\u201349. https:\/\/doi.org\/10.1016\/S0165-3806(01)00110-9.","journal-title":"Dev Brain Res"},{"issue":"4","key":"278_CR95","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF00972477","volume":"13","author":"MK Raizada","year":"1988","unstructured":"Raizada MK, Shemer J, Judkins JH, Clarke DW, Masters BA, LeRoith D. Insulin receptors in the brain: structural and physiological characterization. Neurochem Res. 1988;13(4):297\u2013303. https:\/\/doi.org\/10.1007\/BF00972477.","journal-title":"Neurochem Res"},{"issue":"17","key":"278_CR96","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1523\/JNEUROSCI.19-17-07300.1999","volume":"19","author":"MA Abbott","year":"1999","unstructured":"Abbott MA, Wells DG, Fallon JR. The insulin receptor tyrosine kinase substrate p58\/53 and the insulin receptor are components of CNS synapses. J Neurosci. 1999;19(17):7300\u201308. https:\/\/doi.org\/10.1523\/JNEUROSCI.19-17-07300.1999.","journal-title":"J Neurosci"},{"issue":"3","key":"278_CR97","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.nbd.2004.10.017","volume":"18","author":"PI Moreira","year":"2005","unstructured":"Moreira PI, Santos MS, Sena C, Sei\u00e7a R, Oliveira CR. Insulin protects against amyloid \u03b2-peptide toxicity in brain mitochondria of diabetic rats. Neurobiol Disease. 2005;18(3):628\u201337. https:\/\/doi.org\/10.1016\/j.nbd.2004.10.017.","journal-title":"Neurobiol Disease"},{"issue":"1","key":"278_CR98","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/alz.12192","volume":"17","author":"AFT Arnsten","year":"2021","unstructured":"Arnsten AFT, Datta D, Del Tredici K, Braak H. Hypothesis: tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease. Alzheimers & Dementia. 2021;17(1):115\u201324. https:\/\/doi.org\/10.1002\/alz.12192.","journal-title":"Alzheimers & Dementia"},{"issue":"10","key":"278_CR99","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jalz.2016.01.014","volume":"12","author":"W Hu","year":"2016","unstructured":"Hu W, Zhang X, Tung YC, Xie S, Liu F, Iqbal K. Hyperphosphorylation determines both the spread and the morphology of tau pathology. Alzheimers & Dementia. 2016;12(10):1066\u201377. https:\/\/doi.org\/10.1016\/j.jalz.2016.01.014.","journal-title":"Alzheimers & Dementia"},{"issue":"9","key":"278_CR100","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0024-3205(00)01005-5","volume":"68","author":"M Sharma","year":"2001","unstructured":"Sharma M, Gupta YK. Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci. 2001;68(9):1021\u201329. https:\/\/doi.org\/10.1016\/S0024-3205(00)01005-5.","journal-title":"Life Sci"},{"issue":"1","key":"278_CR101","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5717\/jenb.2014.18.1.89","volume":"18","author":"EB Kang","year":"2014","unstructured":"Kang EB, Cho JY. Effects of treadmill exercise on brain insulin signaling and \u03b2-amyloid in intracerebroventricular streptozotocin induced-memory impairment in rats. J Retailing Exercise Nutr Biochem. 2014;18(1):89\u201396. https:\/\/doi.org\/10.5717\/jenb.2014.18.1.89.","journal-title":"J Retailing Exercise Nutr Biochem"},{"issue":"11","key":"278_CR102","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1586\/14737175.7.11.1527","volume":"7","author":"J Avila","year":"2007","unstructured":"Avila J, Hern\u00e1ndez F. GSK-3 inhibitors for Alzheimer\u2019s disease. Expert Rev Neurotherapeutics. 2007;7(11):1527\u201333. https:\/\/doi.org\/10.1586\/14737175.7.11.1527.","journal-title":"Expert Rev Neurotherapeutics"},{"key":"278_CR103","doi-asserted-by":"crossref","unstructured":"Salkovic-Petrisic M, Hoyer S. Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm, Supplementa. 2007.","DOI":"10.1007\/978-3-211-73574-9_28"},{"key":"278_CR104","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1744-8069-4-9","volume":"4","author":"RM Pabbidi","year":"2008","unstructured":"Pabbidi RM, Yu SQ, Peng S, Khardori R, Pauza ME, Premkumar LS. Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity. Mol Pain. 2008;4:4. https:\/\/doi.org\/10.1186\/1744-8069-4-9.","journal-title":"Mol Pain"},{"issue":"1\u20132","key":"278_CR105","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0006-8993(90)90846-4","volume":"529","author":"SQ Zhu","year":"1990","unstructured":"Zhu SQ, Kum W, Ho SKS, Young JD, Cockram CS. Structure-function relationships of insulin receptor interactions in cultured mouse astrocytes. Brain Res. 1990;529(1\u20132):329\u201332. https:\/\/doi.org\/10.1016\/0006-8993(90)90846-4.","journal-title":"Brain Res"},{"issue":"9","key":"278_CR106","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/cns.12866","volume":"24","author":"I Pomytkin","year":"2018","unstructured":"Pomytkin I, Costa-Nunes JP, Kasatkin V, Veniaminova E, Demchenko A, Lyundup A, et al. Insulin receptor in the brain: mechanisms of activation and the role in the CNS pathology and treatment. CNS Neurosci Ther. 2018;24(9):763\u201374. https:\/\/doi.org\/10.1111\/cns.12866.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"278_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-015-0138-6","volume":"8","author":"CJ Garwood","year":"2015","unstructured":"Garwood CJ, Ratcliffe LE, Morgan SV, Simpson JE, Owens H, Vazquez-Villase\u00f1or I, et al. Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors. Mol Brain. 2015;8(1):1\u201316. https:\/\/doi.org\/10.1186\/s13041-015-0138-6.","journal-title":"Mol Brain"},{"issue":"7","key":"278_CR108","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.2337\/db14-0568","volume":"63","author":"A Kleinridders","year":"2014","unstructured":"Kleinridders A, Ferris HA, Cai W, Kahn CR. Insulin action in brain regulates systemic metabolism and brain function. Diabetes. 2014;63(7):2232\u201343. https:\/\/doi.org\/10.2337\/db14-0568.","journal-title":"Diabetes"},{"issue":"1","key":"278_CR109","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","volume":"136","author":"WA Banks","year":"2012","unstructured":"Banks WA, Owen JB, Erickson MA. Insulin in the brain: there and back again. Pharmacol Ther. 2012;136(1):82\u201393. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.006.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"278_CR110","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2174\/157339913805076454","volume":"9","author":"F Derakhshan","year":"2013","unstructured":"Derakhshan F, Toth C. Insulin and the brain. Curr Diabetes Rev. 2013;9(2):102\u201316. https:\/\/doi.org\/10.2174\/157339913805076454.","journal-title":"Curr Diabetes Rev"},{"issue":"4","key":"278_CR111","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/j.1471-4159.2005.03269.x","volume":"94","author":"LP Van Der Heide","year":"2005","unstructured":"Van Der Heide LP, Kamal A, Artola A, Gispen WH, Ramakers GMJ. Insulin modulates hippocampal activity-dependent synaptic plasticity in a N -methyl- d -aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J Neurochem. 2005 Aug;94(4):1158\u201366. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03269.x.","journal-title":"J Neurochem"},{"issue":"3","key":"278_CR112","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1089\/met.2007.0005","volume":"5","author":"PL Hooper","year":"2007","unstructured":"Hooper PL. Insulin signaling, GSK-3, heat shock proteins and the natural history of type 2 diabetes mellitus: a hypothesis. Metab Syndr Relat Disord. 2007, Sep;5(3):220\u201330. https:\/\/doi.org\/10.1089\/met.2007.0005.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"278_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4209475","volume":"2019","author":"T Jaworski","year":"2019","unstructured":"Jaworski T, Banach-Kasper E, Gralec K. GSK-3\u03b2 at the intersection of neuronal plasticity and neurodegeneration. Neural Plasticity. 2019;2019(1):1\u201314. https:\/\/doi.org\/10.1155\/2019\/4209475.","journal-title":"Neural Plasticity"},{"key":"278_CR114","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fnmol.2012.00013","volume":"5","author":"CA Bradley","year":"2012","unstructured":"Bradley CA, Peineau S, Taghibiglou C, Nicolas CS, Whitcomb DJ, Bortolotto ZA, et al. A pivotal role of GSK-3 in synaptic plasticity. Front Mol Neurosci. 2012;5:13. https:\/\/doi.org\/10.3389\/fnmol.2012.00013.","journal-title":"Front Mol Neurosci"},{"key":"278_CR115","doi-asserted-by":"publisher","unstructured":"Peineau S, Bradley C, Taghibiglou C, Doherty A, Bortolotto ZA, Wang YT, et al. The role of GSK-3 in synaptic plasticity. Br J Pharmacol. 2008;153(S1):S428\u201337. https:\/\/doi.org\/10.1038\/bjp.2008.2.","DOI":"10.1038\/bjp.2008.2"},{"issue":"5","key":"278_CR116","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s00125-002-0818-5","volume":"45","author":"B Valastro","year":"2002","unstructured":"Valastro B, Cossette J, Lavoie N, Gagnon S, Trudeau F, Massicotte G. Up-regulation of glutamate receptors is associated with LTP defects in the early stages of diabetes mellitus. Diabetologia. 2002;45(5):642\u201350. https:\/\/doi.org\/10.1007\/s00125-002-0818-5.","journal-title":"Diabetologia"},{"key":"278_CR117","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuroscience.2012.09.081","volume":"227","author":"S Sasaki-Hamada","year":"2012","unstructured":"Sasaki-Hamada S, Sacai H, Oka JI. Diabetes onset influences hippocampal synaptic plasticity in streptozotocin-treated rats. Neuroscience. 2012;227:293\u2013304. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.09.081.","journal-title":"Neuroscience"},{"key":"278_CR118","doi-asserted-by":"crossref","unstructured":"Lu B, Nagappan G, Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Neurotrophic Factors. 2014;223\u201350.","DOI":"10.1007\/978-3-642-45106-5_9"},{"issue":"4","key":"278_CR119","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/jnr.25022","volume":"100","author":"J Keifer","year":"2022","unstructured":"Keifer J. Regulation of AMPAR trafficking in synaptic plasticity by BDNF and the impact of neurodegenerative disease. J Neurosci Res. 2022;100(4):979\u201391. https:\/\/doi.org\/10.1002\/jnr.25022.","journal-title":"J Neurosci Res"},{"issue":"2","key":"278_CR120","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3892\/mmr.2012.1227","volume":"7","author":"H Yang","year":"2013","unstructured":"Yang H, Fan S, Song D, Wang Z, Ma S, Li S, et al. Long-term streptozotocin-induced diabetes in rats leads to severe damage of brain blood vessels and neurons via enhanced oxidative stress. Mol Med Rep. 2013;7(2):431\u201340. https:\/\/doi.org\/10.3892\/mmr.2012.1227.","journal-title":"Mol Med Rep"},{"issue":"4","key":"278_CR121","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00702-015-1394-4","volume":"122","author":"A Knezovic","year":"2015","unstructured":"Knezovic A, Osmanovic-Barilar J, Curlin M, Hof PR, Simic G, Riederer P, et al. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer\u2019s disease. J Neural Transm. 2015;122(4):577\u201392. https:\/\/doi.org\/10.1007\/s00702-015-1394-4.","journal-title":"J Neural Transm"},{"issue":"7","key":"278_CR122","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0891-5849(03)00408-8","volume":"35","author":"G Baydas","year":"2003","unstructured":"Baydas G, Reiter RJ, Yasar A, Tuzcu M, Akdemir I, Nedzvetskii VS. Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radical Biol Med. 2003;35(7):797\u2013804. https:\/\/doi.org\/10.1016\/S0891-5849(03)00408-8.","journal-title":"Free Radical Biol Med"},{"issue":"2","key":"278_CR123","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s12035-013-8559-7","volume":"49","author":"HK Moghaddam","year":"2014","unstructured":"Moghaddam HK, Baluchnejadmojarad T, Roghani M, Khaksari M, Norouzi P, Ahooie M, et al. Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats. Mol Neurobiol. 2014;49(2):820\u201326. https:\/\/doi.org\/10.1007\/s12035-013-8559-7.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"278_CR124","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12013-024-01248-2","volume":"82","author":"BE Ekundayo","year":"2024","unstructured":"Ekundayo BE, Obafemi TO, Adewale OB, Obafemi BA, Oyinloye BE, Ekundayo SK. Oxidative stress, endoplasmic reticulum stress and apoptosis in the pathology of Alzheimer\u2019s disease. Cell Biochem Biophys. 2024;82(2):457\u201377. https:\/\/doi.org\/10.1007\/s12013-024-01248-2.","journal-title":"Cell Biochem Biophys"},{"issue":"5","key":"278_CR125","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s11357-011-9303-8","volume":"34","author":"S Chen","year":"2012","unstructured":"Chen S, Liu AR, An FM, Yao WB, Gao XD. Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer\u2019s disease by exendin-4. Age (Omaha). 2012;34(5):1211\u201324. https:\/\/doi.org\/10.1007\/s11357-011-9303-8.","journal-title":"Age (Omaha)"},{"key":"278_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/162152","volume":"2013","author":"V Garc\u00eda-Escudero","year":"2013","unstructured":"Garc\u00eda-Escudero V, Mart\u00edn-Maestro P, Perry G, Avila J. Deconstructing mitochondrial dysfunction in Alzheimer disease. Oxidative Med Cellular Longevity. 2013;2013:1\u201313. https:\/\/doi.org\/10.1155\/2013\/162152.","journal-title":"Oxidative Med Cellular Longevity"},{"issue":"10","key":"278_CR127","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3390\/biom12101452","volume":"12","author":"MM Fareed","year":"2022","unstructured":"Fareed MM, Qasmi M, Aziz S, V\u00f6lker E, F\u00f6rster CY, Shityakov S. The role of Clusterin transporter in the pathogenesis of Alzheimer\u2019s disease at the blood\u2013brain barrier interface: a systematic review. Biomolecules. 2022 Oct;12(10):1452. https:\/\/doi.org\/10.3390\/biom12101452.","journal-title":"Biomolecules"},{"issue":"7","key":"278_CR128","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.4103\/1673-5374.160076","volume":"10","author":"PK Kamat","year":"2015","unstructured":"Kamat PK. Streptozotocin induced Alzheimer\u2032s disease like changes and the underlying neural degeneration and regeneration mechanism. Neural Regen Res. 2015;10(7):1050\u201352. https:\/\/doi.org\/10.4103\/1673-5374.160076.","journal-title":"Neural Regen Res"},{"key":"278_CR129","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuint.2017.11.012","volume":"113","author":"SK Mishra","year":"2018","unstructured":"Mishra SK, Singh S, Shukla S, Shukla R. Intracerebroventricular streptozotocin impairs adult neurogenesis and cognitive functions via regulating neuroinflammation and insulin signaling in adult rats. Neurochemistry Int. 2018;113:56\u201368. https:\/\/doi.org\/10.1016\/j.neuint.2017.11.012.","journal-title":"Neurochemistry Int"},{"issue":"6","key":"278_CR130","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00702-017-1727-6","volume":"124","author":"A Knezovic","year":"2017","unstructured":"Knezovic A, Loncar A, Homolak J, Smailovic U, Osmanovic Barilar J, Ganoci L, et al. Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer\u2019s disease? J Neural Transm. 2017;124(6):695\u2013708. https:\/\/doi.org\/10.1007\/s00702-017-1727-6.","journal-title":"J Neural Transm"},{"issue":"8","key":"278_CR131","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2174\/1567205012666150710112618","volume":"12","author":"R Paidi","year":"2015","unstructured":"Paidi R, Nthenge-Ngumbau D, Singh R, Kankanala T, Mehta H, K K. Mitochondrial deficits accompany cognitive decline following single bilateral intracerebroventricular streptozotocin. CAR. 2015;12(8):785\u201395. https:\/\/doi.org\/10.2174\/1567205012666150710112618.","journal-title":"CAR"},{"issue":"7","key":"278_CR132","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.neurobiolaging.2011.02.003","volume":"33","author":"XH Li","year":"2012","unstructured":"Li XH, Lv BL, Xie JZ, Liu J, Zhou XW, Wang JZ. Ages induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation. Neurobiol Aging. 2012;33(7):1400\u201310. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.02.003.","journal-title":"Neurobiol Aging"},{"issue":"23","key":"278_CR133","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.lfs.2006.07.018","volume":"79","author":"AR Pathan","year":"2006","unstructured":"Pathan AR, Viswanad B, Sonkusare SK, Ramarao P. Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci. 2006;79(23):2209\u201316. https:\/\/doi.org\/10.1016\/j.lfs.2006.07.018.","journal-title":"Life Sci"},{"issue":"1","key":"278_CR134","doi-asserted-by":"publisher","first-page":"45971","DOI":"10.1038\/srep45971","volume":"7","author":"Z Guo","year":"2017","unstructured":"Guo Z, Chen Y, Mao YF, Zheng T, Jiang Y, Yan Y, et al. Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer\u2019s rat model. Sci Rep. 2017;7(1):45971. https:\/\/doi.org\/10.1038\/srep45971.","journal-title":"Sci Rep"},{"issue":"3","key":"278_CR135","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12640-016-9684-7","volume":"31","author":"KG Ravelli","year":"2017","unstructured":"Ravelli KG, Ros\u00e1rio B Dos A, Camarini R, Hernandes MS, Britto LR. Intracerebroventricular Streptozotocin as a model of Alzheimer\u2019s disease: neurochemical and behavioral characterization in mice. Neurotox Res. 2017 Apr;31(3):327\u201333. https:\/\/doi.org\/10.1007\/s12640-016-9684-7.","journal-title":"Neurotox Res"},{"issue":"4","key":"278_CR136","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.3390\/ijms25042327","volume":"25","author":"A Wrzesie\u0144","year":"2024","unstructured":"Wrzesie\u0144 A, Andrzejewski K, Jampolska M, Kaczy\u0144ska K. Respiratory dysfunction in Alzheimer\u2019s disease\u2014consequence or underlying cause? Applying animal models to the study of respiratory malfunctions. IJMS. 2024;25(4):2327. https:\/\/doi.org\/10.3390\/ijms25042327.","journal-title":"IJMS"},{"issue":"3","key":"278_CR137","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/ijms23031076","volume":"23","author":"de Paula Faria D","year":"2022","unstructured":"de Paula Faria D, de Souza L, Duran FL de S, Buchpiguel CA, Britto LR, Crippa JA de S, et al. Cannabidiol treatment improves glucose metabolism and memory in streptozotocin-induced Alzheimer\u2019s disease rat model: a proof-of-concept study. IJMS. 2022 Jan;23(3):1076. https:\/\/doi.org\/10.3390\/ijms23031076.","journal-title":"IJMS"},{"issue":"6","key":"278_CR138","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s12640-022-00563-x","volume":"40","author":"A Roy","year":"2022","unstructured":"Roy A, Sharma S, Nag TC, Katyal J, Gupta YK, Jain S. Cognitive dysfunction and anxiety resulting from synaptic downscaling, hippocampal atrophy, and ventricular enlargement with intracerebroventricular streptozotocin injection in male wistar rats. Neurotox Res. 2022;40(6):2179\u2013202. https:\/\/doi.org\/10.1007\/s12640-022-00563-x.","journal-title":"Neurotox Res"},{"key":"278_CR139","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fncel.2014.00022","volume":"8","author":"NB El Khoury","year":"2014","unstructured":"El Khoury NB, Gratuze M, Papon MA, Bretteville A, Planel E. Insulin dysfunction and tau pathology. Front Cell Neurosci. 2014;8:22. https:\/\/doi.org\/10.3389\/fncel.2014.00022.","journal-title":"Front. Cell. Neurosci"},{"key":"278_CR140","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fendo.2014.00161","volume":"5","author":"E Bl\u00c3\u00a1zquez","year":"2014","unstructured":"Bl\u00c3\u00a1zquez E, Vel\u00c3\u00a1zquez E, Hurtado-Carneiro V, Ruiz-Albusac JM. Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and Alzheimer's disease. Front Endocrinol. 2014;5:161. https:\/\/doi.org\/10.3389\/fendo.2014.00161.","journal-title":"Front. Endocrinol"},{"key":"278_CR141","doi-asserted-by":"publisher","unstructured":"Gr?nblatt E, Hoyer S, Riederer P. Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease. J Neural Transm. 2004;111(3):367\u201386. https:\/\/doi.org\/10.1007\/s00702-003-0030-x.","DOI":"10.1007\/s00702-003-0030-x"},{"issue":"2","key":"278_CR142","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s40495-024-00354-2","volume":"10","author":"J Parekh","year":"2024","unstructured":"Parekh J, Shende H, Kumar A, Tuli HS, Kaur G. Assessing the clinical Correlation between Alzheimer\u2019s disease and type-2 diabetes mellitus: current strategies and emerging Perspectives. Curr Pharmacol Rep. 2024;10(2):145\u201358. https:\/\/doi.org\/10.1007\/s40495-024-00354-2.","journal-title":"Curr Pharmacol Rep"},{"issue":"5","key":"278_CR143","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/ph14050458","volume":"14","author":"B Miziak","year":"2021","unstructured":"Miziak B, B\u0142aszczyk B, Czuczwar SJ. Some candidate drugs for pharmacotherapy of Alzheimer\u2019s disease. Pharmaceuticals. 2021;14(5):458. https:\/\/doi.org\/10.3390\/ph14050458.","journal-title":"Pharmaceuticals"},{"key":"278_CR144","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.biopha.2017.08.098","volume":"95","author":"S Gheibi","year":"2017","unstructured":"Gheibi S, Kashfi K, Ghasemi A. A practical guide for induction of type-2 diabetes in rat: incorporating a high-fat diet and streptozotocin. Biomed Pharmacother. 2017 Nov;95:605\u201313. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.098.","journal-title":"Biomed Pharmacother"},{"key":"278_CR145","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cbi.2015.11.032","volume":"244","author":"SN Goyal","year":"2016","unstructured":"Goyal SN, Reddy NM, Patil KR, Nakhate KT, Ojha S, Patil CR, et al. Challenges and issues with streptozotocin-induced diabetes \u2013 a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chemico-Biol Interact. 2016;244:49\u201363. https:\/\/doi.org\/10.1016\/j.cbi.2015.11.032.","journal-title":"Chemico-Biol Interact"},{"issue":"11","key":"278_CR146","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.15419\/bmrat.v6i11.575","volume":"6","author":"O Mahdi","year":"2019","unstructured":"Mahdi O, Baharuldin MTH, Nor NHM, Chiroma SM, Jagadeesan S, Moklas MAM. Chemicals used for the induction of Alzheimer\u2019s disease-like cognitive dysfunctions in rodents. Biomed Res Ther. 2019;6(11):3460\u201384. https:\/\/doi.org\/10.15419\/bmrat.v6i11.575.","journal-title":"Biomed Res Ther"},{"issue":"17\u201318","key":"278_CR147","first-page":"1131","volume":"92","author":"J Mehla","year":"2012","unstructured":"Mehla J, Chauhan BC, Chauhan NB. Experimental models of Alzheimer\u2019s disease: mechanistic insights and therapeutic perspectives. Life Sci. 2012;92(17\u201318):1131\u201338.","journal-title":"Life Sci"},{"key":"278_CR148","doi-asserted-by":"publisher","first-page":"106358","DOI":"10.1016\/j.phrs.2022.106358","volume":"182","author":"BJ Dutta","year":"2022","unstructured":"Dutta BJ, Singh S, Seksaria S, Gupta G Das, Singh A. Inside the diabetic brain: insulin resistance and molecular mechanism associated with cognitive impairment and its possible therapeutic strategies. Pharmacological Res. 2022;182:106358. https:\/\/doi.org\/10.1016\/j.phrs.2022.106358.","journal-title":"Pharmacological Res"},{"issue":"1","key":"278_CR149","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/15569543.2022.2150646","volume":"42","author":"M Wan Chik","year":"2023","unstructured":"Wan Chik M, Ramli NA, Mohamad Nor Hazalin NA, Surindar Singh GK. Streptozotocin mechanisms and its role in rodent models for Alzheimer\u2019s disease. Toxin Rev. 2023;42(1):491\u2013502. https:\/\/doi.org\/10.1080\/15569543.2022.2150646.","journal-title":"Toxin Rev"},{"issue":"1","key":"278_CR150","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/receptors4010002","volume":"4","author":"LCR Teixeira","year":"2025","unstructured":"Teixeira LCR, Luizon MR, Gomes KB. Exploring the role of GLP-1 receptor agonists in Alzheimer\u2019s disease: a review of preclinical and clinical evidence. Receptors. 2025;4(1):2. https:\/\/doi.org\/10.3390\/receptors4010002.","journal-title":"Receptors"},{"issue":"3","key":"278_CR151","first-page":"253","volume":"70","author":"M Labak","year":"2010","unstructured":"Labak M, Wojtowicz T, Salinska E, Czapski GA. STZ-induced model of Alzheimer\u2019s disease: a review of mechanisms. Acta Neurobiol Exp (Wars). 2010;70(3):253\u201360.","journal-title":"Acta Neurobiol Exp (Wars)"},{"issue":"8","key":"278_CR152","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3390\/medicina58080993","volume":"58","author":"KS Alharbi","year":"2022","unstructured":"Alharbi KS, Afzal M, Alzarea SI, Khan SA, Alomar FA, Kazmi I. Rosinidin protects streptozotocin-induced memory impairment-activated neurotoxicity by suppressing oxidative stress and inflammatory mediators in rats. Medicina (B Aires). 2022;58(8):993. https:\/\/doi.org\/10.3390\/medicina58080993.","journal-title":"Medicina (B Aires)"},{"issue":"5","key":"278_CR153","first-page":"1360","volume":"42","author":"KG Ravelli","year":"2017","unstructured":"Ravelli KG, da Silva MH, Avila DS, Pessoa-Pureur R. Delayed object recognition memory deficits and cytoskeletal abnormalities induced by ICV-STZ in rats: relevance to sporadic Alzheimer\u2019s disease. Neurochem Res. 2017;42(5):1360\u201373.","journal-title":"Neurochem Res"},{"key":"278_CR154","unstructured":"Biasibetti R, Tramontina AC, Costa AP, Dutra MF, Lima FD, Batassini C, et al. Hippocampal astrocyte response to streptozotocin-induced neurotoxicity in rats. Brain Res. 1490;170\u201378."},{"key":"278_CR155","unstructured":"Rajkumar R, Shankar R, Nandhakumar M. Galantamine tethered hydrogel mitigates neuroinflammation and cognitive impairment in streptozotocin-induced Alzheimer\u2019s disease in rats. Drug Deliv Transl Res. 12(5):1007\u201319."},{"key":"278_CR156","doi-asserted-by":"crossref","first-page":"118668","DOI":"10.1016\/j.lfs.2020.118668","volume":"264","author":"R Patel","year":"2021","unstructured":"Patel R, Dwivedi P, Chaudhary A, Dubey DK. Andrographolide ameliorates streptozotocin-induced Alzheimer\u2019s disease by suppressing amyloidogenic pathway, oxidative stress, and neuroinflammation. Life Sci. 2021;264:118668.","journal-title":"Life Sci"},{"key":"278_CR157","doi-asserted-by":"publisher","first-page":"112512","DOI":"10.1016\/j.bbr.2020.112512","volume":"383","author":"M Shekarian","year":"2020","unstructured":"Shekarian M, Komaki A, Shahidi S, Sarihi A, Salehi I, Raoufi S. The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (a\u03b2) peptide. Behavioural Brain Res. 2020;383:112512. https:\/\/doi.org\/10.1016\/j.bbr.2020.112512.","journal-title":"Behavioural Brain Res"},{"key":"278_CR158","doi-asserted-by":"publisher","first-page":"662173","DOI":"10.3389\/fphar.2021.662173","volume":"12","author":"A G\u00e1sp\u00e1r","year":"2021","unstructured":"G\u00e1sp\u00e1r A, Hutka B, Ernyey AJ, Tajti BT, Varga BT, Z\u00e1dori ZS, et al. Intracerebroventricularly injected streptozotocin exerts subtle effects on the cognitive performance of long-evans rats. Front Pharmacol. 2021;12:662173. https:\/\/doi.org\/10.3389\/fphar.2021.662173.","journal-title":"Front Pharmacol"},{"issue":"6","key":"278_CR159","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4103\/0253-7613.28213","volume":"38","author":"PA Marathe","year":"2006","unstructured":"Marathe PA, Parekar RR, Shinde SP, Rege NN. A split dose regimen of streptozotocin to induce diabetes in a neonatal rat model. Indian J Pharmacol. 2006;38(6):432\u201333. https:\/\/doi.org\/10.4103\/0253-7613.28213.","journal-title":"Indian J Pharmacol"},{"key":"278_CR160","doi-asserted-by":"crossref","unstructured":"Lewis DH, Toney LK, Baron JC. Nuclear medicine in cerebrovascular disease. In: Seminars in nuclear medicine. Elsevier; 2012. p. 387\u2013405.","DOI":"10.1053\/j.semnuclmed.2012.06.002"},{"issue":"2","key":"278_CR161","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/pharmaceutics14020235","volume":"14","author":"AV Lupaescu","year":"2022","unstructured":"Lupaescu AV, Iavorschi M, Covasa M. The use of bioactive compounds in hyperglycemia- and amyloid fibrils-induced toxicity in type 2 diabetes and Alzheimer\u2019s disease. Pharmaceutics. 2022;14(2):235. https:\/\/doi.org\/10.3390\/pharmaceutics14020235.","journal-title":"Pharmaceutics"},{"key":"278_CR162","doi-asserted-by":"crossref","unstructured":"Kamat PK, Kalani A, Rai S, Tota SK, Kumar A, Ahmad AS. Streptozotocin intracerebroventricular-induced neurotoxicity and brain insulin resistance: a therapeutic Intervention for treatment of sporadic Alzheimer\u2019s disease (sAD)-like pathology. Vol. 53. Molecular Neurobiology; 2016.","DOI":"10.1007\/s12035-015-9384-y"},{"key":"278_CR163","doi-asserted-by":"publisher","unstructured":"Moreira-Silva D, Vizin RCL, Martins TMS, Ferreira TL, Almeida MC, Carrettiero DC. Intracerebral injection of streptozotocin to model Alzheimer disease in rats. Bio-protocol. 2019;9(20):e3397\u2013e 3397. https:\/\/doi.org\/10.21769\/BioProtoc.3397.","DOI":"10.21769\/BioProtoc.3397"},{"key":"278_CR164","doi-asserted-by":"publisher","first-page":"1455434","DOI":"10.3389\/fphys.2025.1455434","volume":"16","author":"MT Venuti","year":"2025","unstructured":"Venuti MT, Roda E, Brandalise F, Sarkar M, Cappelletti M, Speciani AF, et al. A pathophysiological intersection between metabolic biomarkers and memory: a longitudinal study in the STZ-induced diabetic mouse model. Front. Physiol. 2025;16:1455434. https:\/\/doi.org\/10.3389\/fphys.2025.1455434.","journal-title":"Front. Physiol"},{"issue":"7","key":"278_CR165","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2174\/0115672050399032250715043316","volume":"22","author":"Z Xing","year":"2025","unstructured":"Xing Z, Jiang X, Yang W, Wang Y, Zhang X, Zhao C. Lithium Chloride improves Electrophysiological and memory deficits in rats with streptozotocin-induced Alzheimer\u2019s disease. CAR. 2025;22(7):536\u201347. https:\/\/doi.org\/10.2174\/0115672050399032250715043316.","journal-title":"CAR"},{"issue":"10","key":"278_CR166","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00702-025-02952-w","volume":"132","author":"J Homolak","year":"2025","unstructured":"Homolak J, Markovic P, Virag D, Knezovic A, Osmanovic Barilar J, Loncar A, et al. Species-specific sensitivity to intracerebroventricular streptozotocin in rats and mice highlights pathways and proteins relevant to Alzheimer\u2019s disease. J. Homolak, Et Al J Neural Transm. 2025;132(10):1547\u201366. https:\/\/doi.org\/10.1007\/s00702-025-02952-w.","journal-title":"J. Homolak, Et Al J Neural Transm"},{"issue":"13","key":"278_CR167","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1021\/acschemneuro.5c00139","volume":"16","author":"TK Hall","year":"2025","unstructured":"Hall TK, Paim MP, da Costa P, de Azevedo AR, Nascimento V, Neto JSS, et al. Neuroprotective effects of a benzofuran-containing Selenium in a mouse Alzheimer\u2019s disease model: molecular, biochemical, and behavioral analyses. ACS Chem. Neurosci. 2025;16(13):2420\u201334. https:\/\/doi.org\/10.1021\/acschemneuro.5c00139.","journal-title":"ACS Chem. Neurosci"},{"issue":"2","key":"278_CR168","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2174\/0113892010331845240802073645","volume":"26","author":"V Kushwaha","year":"2025","unstructured":"Kushwaha V, Sahu KK. A Comprehensive review on preclinical Alzheimer\u2019s disease models: evaluating their clinical Relevance. CPB. 2025;26(2):186\u2013207. https:\/\/doi.org\/10.2174\/0113892010331845240802073645.","journal-title":"CPB"},{"issue":"8","key":"278_CR169","doi-asserted-by":"publisher","first-page":"10443","DOI":"10.1007\/s12035-025-04910-9","volume":"62","author":"K Rustage","year":"2025","unstructured":"Rustage K, Rai N, Sinha SK, Goyal J, Chouhan P, Baniya B, et al. Evaluation of the sporadic anti-Alzheimer\u2019s activity of purpurin using in Silico, in vitro, and in vivo Approaches. Vitro, In Vivo Approaches. Mol Neurobiol. 2025;62(8):10443\u201367. https:\/\/doi.org\/10.1007\/s12035-025-04910-9.","journal-title":"Vitro, In Vivo Approaches. Mol Neurobiol"},{"key":"278_CR170","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.biopha.2018.03.115","volume":"102","author":"P Barai","year":"2018","unstructured":"Barai P, Raval N, Acharya S, Acharya N. Bergenia ciliata ameliorates streptozotocin-induced spatial memory deficits through dual cholinesterase inhibition and attenuation of oxidative stress in rats. Biomed Pharmacother. 2018;102:966\u201380. https:\/\/doi.org\/10.1016\/j.biopha.2018.03.115.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"278_CR171","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/bpa.12116","volume":"24","author":"C Gao","year":"2014","unstructured":"Gao C, Liu Y, Jiang Y, Ding J, Li L. Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK 3\u03b2 pathway in streptozotocin-induced a lzheimer rat model. Brain Pathol. 2014;24(3):261\u201369. https:\/\/doi.org\/10.1111\/bpa.12116.","journal-title":"Brain Pathol"},{"key":"278_CR172","doi-asserted-by":"publisher","first-page":"113725","DOI":"10.1016\/j.jep.2020.113725","volume":"269","author":"HL Zhao","year":"2021","unstructured":"Zhao HL, Cui SY, Qin Y, Liu YT, Cui XY, Hu X, et al. Prophylactic effects of sporoderm-removed Ganoderma lucidum spores in a rat model of streptozotocin-induced sporadic Alzheimer\u2019s disease. J Ethnopharmacol. 2021 Apr;269:113725. https:\/\/doi.org\/10.1016\/j.jep.2020.113725.","journal-title":"J Ethnopharmacol"},{"key":"278_CR173","unstructured":"Barai P, others. Neuroprotective effect of Bergenin against ICV-STZ-induced Alzheimer\u2019s disease in rats. J Ethnopharmacol. 2019;232:123\u201335."},{"key":"278_CR174","doi-asserted-by":"publisher","first-page":"100100","DOI":"10.1016\/j.crphar.2022.100100","volume":"3","author":"M Rajkumar","year":"2022","unstructured":"Rajkumar M, Sakthivel M, Senthilkumar K, Thangaraj R, Kannan S. Galantamine tethered hydrogel as a novel therapeutic target for streptozotocin-induced Alzheimer\u2019s disease in Wistar rats. Curr Res Pharmacol Drug Discov. 2022;3:100100. https:\/\/doi.org\/10.1016\/j.crphar.2022.100100.","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"278_CR175","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3389\/fnins.2018.00653","volume":"12","author":"D Moreira-Silva","year":"2018","unstructured":"Moreira-Silva D, Carrettiero DC, Oliveira ASA, Rodrigues S, dos Santos-Lopes J, Canas PM, et al. Anandamide effects in a streptozotocin-induced Alzheimer\u2019s disease-like sporadic dementia in rats. Front Neurosci. 2018;12:653. https:\/\/doi.org\/10.3389\/fnins.2018.00653.","journal-title":"Front. Neurosci"},{"key":"278_CR176","doi-asserted-by":"publisher","unstructured":"e Silva TG de S, da Silva JRM, da Silva Alves A, Britto LRG, Xavier GF, Sandoval MRL. Oral treatment with royal jelly improves memory and presents neuroprotective effects on icv-STZ rat model of sporadic Alzheimer\u2019s disease. Heliyon. 2020;6(2):e03281. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03281.","DOI":"10.1016\/j.heliyon.2020.e03281"},{"key":"278_CR177","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbr.2017.10.002","volume":"337","author":"SP Navabi","year":"2018","unstructured":"Navabi SP, Sarkaki A, Mansouri E, Badavi M, Ghadiri A, Farbood Y. The effects of betulinic acid on neurobehavioral activity, electrophysiology and histological changes in an animal model of the Alzheimer\u2019s disease. Behavioural Brain Res [Internet]. 2018;337:99\u2013106. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0166432817310495.","journal-title":"Behavioural Brain Res"},{"key":"278_CR178","doi-asserted-by":"publisher","first-page":"148202","DOI":"10.1016\/j.brainres.2022.148202","volume":"1801","author":"CM Humphrey","year":"2023","unstructured":"Humphrey CM, Hooker JW IV, Thapa M, Wilcox MJ, Ostrowski D, Ostrowski TD. Synaptic loss and gliosis in the nucleus tractus solitarii with streptozotocin-induced Alzheimer\u2019s disease. Brain Res. 2023;1801:148202. https:\/\/doi.org\/10.1016\/j.brainres.2022.148202.","journal-title":"Brain Res"},{"issue":"21","key":"278_CR179","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/S0024-3205(02)02083-0","volume":"71","author":"M Sharma","year":"2002","unstructured":"Sharma M, Gupta YK. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci. 2002;71(21):2489\u201398. https:\/\/doi.org\/10.1016\/S0024-3205(02)02083-0.","journal-title":"Life Sci"},{"issue":"8","key":"278_CR180","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/abbs\/gmx059","volume":"49","author":"F Lu","year":"2017","unstructured":"Lu F, Li X, Li W, Wei K, Yao Y, Zhang Q, et al. Tetramethylpyrazine reverses intracerebroventricular streptozotocin-induced memory deficits by inhibiting GSK-3\u03b2. ABBS. 2017;49(8):722\u201328. https:\/\/doi.org\/10.1093\/abbs\/gmx059.","journal-title":"ABBS"},{"key":"278_CR181","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.expneurol.2018.10.012","volume":"311","author":"AG Brown","year":"2019","unstructured":"Brown AG, Thapa M, Hooker JW, Ostrowski TD. Impaired chemoreflex correlates with decreased c-Fos in respiratory brainstem centers of the streptozotocin-induced Alzheimer\u2019s disease rat model. Exp Neurol. 2019;311:285\u201392. https:\/\/doi.org\/10.1016\/j.expneurol.2018.10.012.","journal-title":"Exp Neurol"},{"issue":"1","key":"278_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-016-0119-y","volume":"11","author":"SF Kazim","year":"2016","unstructured":"Kazim SF, Iqbal K. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer\u2019s disease. Mol Neurodegener. 2016;11(1):1\u201316. https:\/\/doi.org\/10.1186\/s13024-016-0119-y.","journal-title":"Mol Neurodegener"},{"key":"278_CR183","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.nbd.2014.07.001","volume":"71","author":"SF Kazim","year":"2014","unstructured":"Kazim SF, Blanchard J, Dai CL, Tung YC, LaFerla FM, Iqbal IG, et al. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Disease. 2014;71:110\u201330. https:\/\/doi.org\/10.1016\/j.nbd.2014.07.001.","journal-title":"Neurobiol Disease"},{"issue":"1","key":"278_CR184","doi-asserted-by":"publisher","first-page":"20247","DOI":"10.1038\/s41598-022-24292-5","volume":"12","author":"A G\u00e1sp\u00e1r","year":"2022","unstructured":"G\u00e1sp\u00e1r A, Hutka B, Ernyey AJ, Tajti BT, Varga BT, Z\u00e1dori ZS, et al. Performance of the intracerebroventricularly injected streptozotocin Alzheimer\u2019s disease model in a translationally relevant, aged and experienced rat population. Sci Rep. 2022;12(1):20247. https:\/\/doi.org\/10.1038\/s41598-022-24292-5.","journal-title":"Sci Rep"},{"key":"278_CR185","unstructured":"Bernardo T. Physical exercise as a preventive and therapeutic strategy against behavioral dysfunction in Alzheimer\u2019s disease. Universidade do Porto (Portugal). 2019."},{"key":"278_CR186","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1007\/s12035-017-0645-9","volume":"55","author":"TB Bassani","year":"2017","unstructured":"Bassani TB, Bonato JM, Machado MMF, C\u00f3ppola-Segovia V, Moura ELR, Zanata SM, et al. Decrease in adult neurogenesis and neuroinflammation are involved in spatial memory impairment in the streptozotocin-induced model of sporadic Alzheimer\u2019s disease in rats. Mol Neurobiol. 2017;55:4280\u201396. https:\/\/doi.org\/10.1007\/s12035-017-0645-9.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"278_CR187","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4315038","volume":"2019","author":"P Yuan","year":"2019","unstructured":"Yuan P, Zhang J, Li L, Song Z. Fluoxetine attenuated anxiety-like behaviors in streptozotocin-induced diabetic mice by mitigating the inflammation. Mediators Inflammation. 2019;2019(1):1\u20138. https:\/\/doi.org\/10.1155\/2019\/4315038.","journal-title":"Mediators Inflammation"},{"key":"278_CR188","unstructured":"Sakimura K. Studies on mechanisms of depression and blunted circadian rhythm in Spontaneously Diabetic Torii (SDT) fatty rats. 2019."},{"key":"278_CR189","doi-asserted-by":"publisher","unstructured":"Roostaei A, Vaezi G, Nasehi M, Haeri-Rohani A, Zarrindast MR. Study of the role of dopamine receptors in streptozotocin-induced depressive-like behavior using the forced swim test model. GMJ. 2017;7:e954. https:\/\/doi.org\/10.31661\/gmj.v7i0.954.","DOI":"10.31661\/gmj.v7i0.954"},{"key":"278_CR190","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbr.2013.10.011","volume":"258","author":"de Morais H","year":"2014","unstructured":"de Morais H, de Souza Cp, da Silva Lm, Ferreira DM, Werner MF, Andreatini R, et al. Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats. Behavioural Brain Res. 2014;258:52\u201364. https:\/\/doi.org\/10.1016\/j.bbr.2013.10.011.","journal-title":"Behavioural Brain Res"},{"key":"278_CR191","doi-asserted-by":"publisher","first-page":"1265134","DOI":"10.3389\/fnins.2023.1265134","volume":"17","author":"M Taha","year":"2023","unstructured":"Taha M, Mahmoud ME, Al-Kushi AG, Sarhan A, Abdelbagi O, Baokbah TAS, et al. Anxiolytic and antidepressant like effects of Zamzam water in STZ-induced diabetic rats, targeting oxidative stress, neuroinflammation, BDNF\/ERK\/CREP pathway with modulation of hypothalamo-pituitary\u2013adrenal axis. Front. Neurosci. 2023;17:1265134. https:\/\/doi.org\/10.3389\/fnins.2023.1265134.","journal-title":"Front. Neurosci"},{"key":"278_CR192","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuro.2021.05.016","volume":"85","author":"W Jiang","year":"2021","unstructured":"Jiang W, Tang YY, Zhu WW, Li C, Zhang P, Li RQ, et al. PI3K\/AKT pathway mediates the antidepressant- and anxiolytic-like roles of hydrogen sulfide in streptozotocin-induced diabetic rats via promoting hippocampal neurogenesis. Neurotoxicology. 2021;85:201\u201308. https:\/\/doi.org\/10.1016\/j.neuro.2021.05.016.","journal-title":"Neurotoxicology"},{"key":"278_CR193","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.biopha.2018.02.052","volume":"101","author":"KT Nakhate","year":"2018","unstructured":"Nakhate KT, Bharne AP, Verma VS, Aru DN, Kokare DM. Plumbagin ameliorates memory dysfunction in streptozotocin induced Alzheimer\u2019s disease via activation of Nrf2\/ARE pathway and inhibition of \u03b2-secretase. Biomed Pharmacother. 2018 May;101:379\u201390. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.052.","journal-title":"Biomed Pharmacother"},{"key":"278_CR194","doi-asserted-by":"publisher","first-page":"148202","DOI":"10.1016\/j.brainres.2022.148202","volume":"1801","author":"CM Humphrey","year":"2023","unstructured":"Humphrey CM, Hooker JW, Thapa M, Wilcox MJ, Ostrowski D, Ostrowski TD. Synaptic loss and gliosis in the nucleus tractus solitarii with streptozotocin-induced Alzheimer\u2019s disease. 2022. Brain Res. 2023;1801:148202. https:\/\/doi.org\/10.1016\/j.brainres.2022.148202.","journal-title":"Brain Res"},{"issue":"8","key":"278_CR195","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s11064-022-03640-x","volume":"47","author":"J Dhaliwal","year":"2022","unstructured":"Dhaliwal J, Dhaliwal N, Akhtar A, Kuhad A, Chopra K. Tetramethylpyrazine attenuates cognitive impairment via suppressing oxidative stress, neuroinflammation, and apoptosis in type 2 diabetic rats. Neurochem Res. 2022;47(8):2431\u201344. https:\/\/doi.org\/10.1007\/s11064-022-03640-x.","journal-title":"Neurochem Res"},{"issue":"2","key":"278_CR196","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12640-022-00482-x","volume":"40","author":"N Hasan","year":"2022","unstructured":"Hasan N, Zameer S, Najmi AK, Parvez S, Akhtar M. RETRACTED ARTICLE: roflumilast reduces pathological symptoms of sporadic Alzheimer\u2019s disease in rats produced by Intracerebroventricular Streptozotocin by inhibiting NF-\u03baB\/BACE-1 mediated A\u03b2 production in the hippocampus and activating the cAMP\/BDNF signalling pathway. Neurotox Res. 2022;40(2):432\u201348. https:\/\/doi.org\/10.1007\/s12640-022-00482-x.","journal-title":"Neurotox Res"},{"key":"278_CR197","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.neuroscience.2012.02.046","volume":"210","author":"H Javed","year":"2012","unstructured":"Javed H, Khan MM, Ahmad A, Vaibhav K, Ahmad ME, Khan A, et al. Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type. Neuroscience. 2012;210:340\u201352. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.02.046.","journal-title":"Neuroscience"},{"key":"278_CR198","doi-asserted-by":"publisher","first-page":"150925","DOI":"10.1016\/j.bbrc.2024.150925","volume":"737","author":"K Nagori","year":"2024","unstructured":"Nagori K, Pradhan M, Nakhate KT. Ethyl gallate ameliorates diabetes-induced Alzheimer\u2019s disease-like phenotype in rats via activation of \u03b17 nicotinic receptors and mitigation of oxidative stress. Biochem Bioph Res Co. 2024;737:150925. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150925.","journal-title":"Biochem Bioph Res Co"},{"issue":"1","key":"278_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2004.10.036","volume":"77","author":"S Sonkusare","year":"2005","unstructured":"Sonkusare S, Srinivasan K, Kaul C, Ramarao P. Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats. Life Sci. 2005 May;77(1):1\u201314. https:\/\/doi.org\/10.1016\/j.lfs.2004.10.036.","journal-title":"Life Sci"},{"issue":"6","key":"278_CR200","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12640-025-00771-1","volume":"43","author":"AFK Vizuete","year":"2025","unstructured":"Vizuete AFK, Moreira AP, Zin LEF, de Oliveira Marques C, Pacheco RF, Leal MB, et al. Neuroprotective roles of metformin in a streptozotocin-induced dementia model in rats. Neurotox Res. 2025;43(6):48. https:\/\/doi.org\/10.1007\/s12640-025-00771-1.","journal-title":"Neurotox Res"},{"issue":"1","key":"278_CR201","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s12035-024-04299-x","volume":"62","author":"JR Bezerra","year":"2025","unstructured":"Bezerra JR, de Souza Nascimento T, Tavares J, de Aguiar MSS, Maia MVV, de Andrade GM. Neuroprotective effect of chlorogenic acid in an animal model of sporadic Alzheimer\u2019s disease induced by Streptozotocin. Mol Neurobiol. 2025;62(1):674\u201392. https:\/\/doi.org\/10.1007\/s12035-024-04299-x.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"278_CR202","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11571-017-9471-z","volume":"12","author":"D Wang","year":"2018","unstructured":"Wang D, Wang C, Liu L, Li S. Protective effects of evodiamine in experimental paradigm of Alzheimer\u2019s disease. Cogn Neurodyn. 2018;12(3):303\u201313. https:\/\/doi.org\/10.1007\/s11571-017-9471-z.","journal-title":"Cogn Neurodyn"},{"issue":"7","key":"278_CR203","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s00213-021-05826-7","volume":"238","author":"A Akhtar","year":"2021","unstructured":"Akhtar A, Dhaliwal J, Sah SP. 7, 8-dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer\u2019s disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance. Psychopharmacol (Berl). 2021;238(7):1991\u20132009. https:\/\/doi.org\/10.1007\/s00213-021-05826-7.","journal-title":"Psychopharmacol (Berl)"},{"issue":"9","key":"278_CR204","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41401-020-00562-8","volume":"42","author":"L Zhu","year":"2021","unstructured":"Zhu L, Hou X-J, Che X-H, Zhou T-S, Liu X-Q, Wu C-F, et al. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer\u2019s disease rat model. Acta Pharmacol Sin. 2021;42(9):1401\u201308. https:\/\/doi.org\/10.1038\/s41401-020-00562-8.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"278_CR205","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1007\/s10787-023-01313-x","volume":"31","author":"M Rajkumar","year":"2023","unstructured":"Rajkumar M, Kannan S, Thangaraj R. Voglibose attenuates cognitive impairment, A\u03b2 aggregation, oxidative stress, and neuroinflammation in streptozotocin-induced Alzheimer\u2019s disease rat model. Inflammopharmacology. 2023;31(5):2751\u201371. https:\/\/doi.org\/10.1007\/s10787-023-01313-x.","journal-title":"Inflammopharmacology"},{"key":"278_CR206","doi-asserted-by":"crossref","unstructured":"Yuan P, Zhang J, Li L, Song Z. Fluoxetine attenuated anxiety-like behaviors in streptozotocin-induced diabetic mice by mitigating the inflammation. Media. 2019;2019:4315038.","DOI":"10.1155\/2019\/4315038"},{"key":"278_CR207","volume-title":"Differential effects of diazepam on anxiety in streptozotocin induced diabetic and non-diabetic rats Psychopharmacology","author":"M Ramanathan","year":"1998","unstructured":"Ramanathan M. Differential effects of diazepam on anxiety in streptozotocin induced diabetic and non-diabetic rats Psychopharmacology. Psychopharmacology; 1998."},{"key":"278_CR208","volume-title":"The rat brain in stereotaxic coordinates-the New coronal set","author":"G Paxinos","year":"2004","unstructured":"Paxinos G, Watson C. The rat brain in stereotaxic coordinates-the New coronal set. Elsevier; 2004."},{"issue":"1","key":"278_CR209","first-page":"51","volume":"16","author":"A Lourbopoulos","year":"2012","unstructured":"Lourbopoulos A, Chatzigeorgiou S, Mavridis T, Kokkinakis I, Tascos N, Simeonidou C. Stereotactic coordinates for intracerebroventricular infusion after permanent focal cerebral ischemia in Wistar rats. Hippokratia. 2012;16(1):51.","journal-title":"Hippokratia"},{"key":"278_CR210","volume-title":"Paxinos and Franklin\u2019s the mouse brain in stereotaxic coordinates, compact: the coronal plates and diagrams","author":"KBJ Franklin","year":"2019","unstructured":"Franklin KBJ, Paxinos G. Paxinos and Franklin\u2019s the mouse brain in stereotaxic coordinates, compact: the coronal plates and diagrams. Academic press; 2019."},{"key":"278_CR211","volume-title":"Paxinos and Franklin\u2019s the mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2019","unstructured":"Paxinos G, Franklin KBJ. Paxinos and Franklin\u2019s the mouse brain in stereotaxic coordinates. Academic press; 2019."},{"key":"278_CR212","doi-asserted-by":"crossref","unstructured":"Zamboni M. Injection and infusion of compounds to the central nervous system. In: Oligonucleotide-based therapies: methods and protocols. Springer; 2019. p. 237\u201348.","DOI":"10.1007\/978-1-4939-9670-4_14"},{"issue":"3","key":"278_CR213","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3349\/ymj.2014.55.3.689","volume":"55","author":"J Song","year":"2014","unstructured":"Song J, Hur BE, Bokara KK, Yang W, Cho HJ, Park KA, et al. Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model. Yonsei Med J. 2014;55(3):689\u201399. https:\/\/doi.org\/10.3349\/ymj.2014.55.3.689.","journal-title":"Yonsei Med J"},{"key":"278_CR214","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejmech.2018.09.031","volume":"158","author":"Q Li","year":"2018","unstructured":"Li Q, He S, Chen Y, Feng F, Qu W, Sun H. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2018;158:463\u201377. https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.031.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"278_CR215","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","volume":"53","author":"PK Kamat","year":"2016","unstructured":"Kamat PK, Kalani A, Rai S, Swarnkar S, Tota S, Nath C, et al. Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s disease: understanding the therapeutics strategies. Mol Neurobiol. 2016;53(1):648\u201361. https:\/\/doi.org\/10.1007\/s12035-014-9053-6.","journal-title":"Mol Neurobiol"},{"issue":"1\u20132","key":"278_CR216","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0303-7207(01)00455-5","volume":"177","author":"WQ Zhao","year":"2001","unstructured":"Zhao WQ, Alkon DL. Role of insulin and insulin receptor in learning and memory. Mol Cellular Endocrinol. 2001;177(1\u20132):125\u201334. https:\/\/doi.org\/10.1016\/S0303-7207(01)00455-5.","journal-title":"Mol Cellular Endocrinol"},{"issue":"1","key":"278_CR217","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/187152708783885156","volume":"7","author":"G Perry","year":"2008","unstructured":"PI M. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord. 2008;7(1):3\u201310. https:\/\/doi.org\/10.2174\/187152708783885156.","journal-title":"CNSNDDT"},{"issue":"5\u20136","key":"278_CR218","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1046\/j.1440-1681.2003.03842.x","volume":"30","author":"MH Veerendra Kumar","year":"2003","unstructured":"Veerendra Kumar MH, Gupta YK. Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer\u2019s disease in rats. Clin Exp Pharma Physio. 2003;30(5\u20136):336\u201342. https:\/\/doi.org\/10.1046\/j.1440-1681.2003.03842.x.","journal-title":"Clin Exp Pharma Physio"}],"container-title":["Laboratory Animal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00278-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42826-026-00278-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00278-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:55:38Z","timestamp":1781646938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42826-026-00278-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":218,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["278"],"URL":"https:\/\/doi.org\/10.1186\/s42826-026-00278-6","relation":{},"ISSN":["2233-7660"],"issn-type":[{"value":"2233-7660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}